UNSPSC 51422601: Dexamethasone/lidocaine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class HS051. This VA Drug Class (HS051) classifies this compound as belonging to the group GLUCOCORTICOIDS.

UNSPSC 51422601 Dexamethasone/lidocaine is a Commodity code that captures pharmaceutical products and drug-delivery systems procured by state and local health agencies. Recent solicitations under this code show state and local governments buying naloxone (opioid-overdose reversal medication) and drug deactivation systems for community health programs, rather than the specific steroid-anesthetic combination the code name suggests. The issuing bodies include county health departments and state health and human services agencies conducting competitive procurement through IFB, RFI, and RFP mechanisms. Vendors must meet standard compliance requirements including E-Verify, drug-free workplace certification, commercial general liability insurance, and in some cases federal requirements tied to FEMA funding or state pharmacy benefit program regulations.

Recent activity spans Florida and Texas. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the county community health building in Sanford, with a response deadline of July 26, 2023, and a two-year initial term with one-year renewal option. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor information on direct-to-manufacturer prescription fulfillment capabilities for a Therapeutic Pharmacy Initiative program targeting self-insured employee health plans and state agencies, positioned as a precursor to a formal RFP. Neither opportunity specifies explicit set-asides for disadvantaged enterprises, though both require federal compliance standards and vendor qualification documentation.